arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

HYPERION DEFI, INC.

HYPD
$2.71 ▲ +0.04 (+1.50%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

HYPERION DEFI, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $13.6M
Dividend Yield
Revenue Growth 1318.8%
Op. Margin None
ROIC -89.9%
FCF / Share $-2.95
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$813.46K
↑ +1318.8%
Net Income Profit after all expenses
$-45.31M
↑ +9.0%
FCF / Share Free cash flow per share
$-2.95
↑ +91.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
8
Financial Health
12
Cash Quality
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 39 quarters